Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             118 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A comprehensive review of official discount rates in guidelines of health economic evaluations over time: the trends and roots Khorasani, Elahe

9 p. 1577-1590
artikel
2 A direct method for the identification of patterns of care using administrative databases: the case of breast cancer Busco, Susanna

9 p. 1477-1485
artikel
3 A European multinational cost-effectiveness analysis of empagliflozin in heart failure with reduced ejection fraction Tafazzoli, Ali

9 p. 1441-1454
artikel
4 A methodological proposal to evaluate the cost of duration moral hazard in workplace accident insurance Martín-Román, Ángel
2017
9 p. 1181-1198
artikel
5 Analysing coverage decision-making: opening Pandora’s box? Fischer, Katharina Elisabeth
2014
9 p. 899-906
artikel
6 An examination of the relationships between service use and alternative measures of obesity among community-dwelling adults in Ireland Doherty, Edel
2014
9 p. 951-956
artikel
7 Are costs derived from diagnosis-related groups suitable for use in economic evaluations? A comparison across nine European countries in the European Healthcare and Social Cost Database Špacírová, Zuzana

9 p. 1563-1575
artikel
8 A review of economic evaluation models for cardiac resynchronization therapy with implantable cardioverter defibrillators in patients with heart failure Tomini, F.
2016
9 p. 1159-1172
artikel
9 Brand switching or reduced consumption? A study of how cigarette taxes affect tobacco consumption Chen, Chiang-Ming
2013
9 p. 991-998
artikel
10 Budget impact analysis of the use of oral and intravenous therapy regimens for the treatment of relapsed or refractory multiple myeloma in Germany Basic, Edin

9 p. 1351-1361
artikel
11 Budget impact of parenteral iron treatment of iron deficiency: methodological issues raised by using real-life data Brock, Elisabeth
2013
9 p. 907-916
artikel
12 Burden of disease in multiple sclerosis patients with spasticity in Germany: mobility improvement study (Move I) Zettl, Uwe K.
2013
9 p. 953-966
artikel
13 Comparing the measurement properties of the ICECAP-A and ICECAP-O instruments in ages 50–70: a cross-sectional study on a representative sample of the Hungarian general population Baji, Petra

9 p. 1453-1466
artikel
14 Comparison of the preference-based EQ-5D-5L and SF-6D in patients with end-stage renal disease (ESRD) Yang, Fan
2014
9 p. 1019-1026
artikel
15 Correction to: Cost‑effectiveness analysis of stand‑alone or combined non‑invasive imaging tests for the diagnosis of stable coronary artery disease: results from the EVINCI study Lorenzoni, Valentina

9 p. 1451
artikel
16 Correction to: Time and lexicographic preferences in the valuation of EQ-5D-Y with time trade-off methodology Lipman, Stefan A.

9 p. 1613-1615
artikel
17 Cost analysis and cost-benefit analysis of a medication review with follow-up service in aged polypharmacy patients Malet-Larrea, Amaia
2016
9 p. 1069-1078
artikel
18 Cost and cost-effectiveness of four different SARS-CoV-2 active surveillance strategies: evidence from a randomised control trial in Germany Nguyen, Hoa Thi

9 p. 1545-1559
artikel
19 Cost-effectiveness analysis of stand-alone or combined non-invasive imaging tests for the diagnosis of stable coronary artery disease: results from the EVINCI study Lorenzoni, Valentina

9 p. 1437-1449
artikel
20 Cost-effectiveness of enhancing a Quit-and-Win smoking cessation program for college students Popp, Jonah
2018
9 p. 1319-1333
artikel
21 Cost-effectiveness of linaclotide compared to antidepressants in the treatment of irritable bowel syndrome with constipation in Scotland Fisher, Mark
2016
9 p. 1091-1100
artikel
22 Cost-effectiveness of ravulizumab compared with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria in the Netherlands Quist, S. W.

9 p. 1455-1472
artikel
23 Cost-effectiveness of smoking cessation programs for hospitalized patients: a systematic review Lee, Donghoon

9 p. 1409-1424
artikel
24 Cost effects of hospital mergers in Portugal Azevedo, Helda
2013
9 p. 999-1010
artikel
25 Costs and benefits of interventions aimed at major infectious disease threats: lessons from the literature Kellerborg, Klas

9 p. 1329-1350
artikel
26 Cost–utility analysis of an intervention designed to reduce the critical handling error of insufficient inspiratory effort Forster, Rebecca
2018
9 p. 1303-1318
artikel
27 Cost-utility of ranolazine for the symptomatic treatment of patients with chronic angina pectoris in Spain Hidalgo-Vega, Álvaro
2013
9 p. 917-925
artikel
28 Determinants of utilisation differences for cancer medicines in Belgium, Scotland and Sweden Ferrario, Alessandra
2016
9 p. 1095-1105
artikel
29 Determinants of willingness to pay for health services: a systematic review of contingent valuation studies Steigenberger, Caroline

9 p. 1455-1482
artikel
30 Diffusion of pharmaceuticals: cross-country evidence of anti-TNF drugs Brekke, Kurt Richard
2013
9 p. 937-951
artikel
31 Does smoke cross the border? Cigarette tax avoidance in France Ben Lakhdar, Christian
2015
9 p. 1073-1089
artikel
32 Does uptake of specialty care affect HRQoL development in COPD patients beneficially? A difference-in-difference analysis linking claims and survey data Stöber, Alisa

9 p. 1561-1573
artikel
33 Do renewable energy and health expenditures improve load capacity factor in the USA and Japan? A new approach to environmental issues Pata, Ugur Korkut

9 p. 1427-1439
artikel
34 Driving time drives the hospital choice: choice models for pelvic organ prolapse surgery in Italy Ferrari, Amerigo

9 p. 1575-1586
artikel
35 Early start of anti-dementia medication is associated with lower health and social care costs in Alzheimer´s patients: a Finnish nationwide register study Vesikansa, Aino

9 p. 1421-1428
artikel
36 Economic evaluation of personalized medicine: a call for real-world data Terkola, Robert
2017
9 p. 1065-1067
artikel
37 Economic evaluation of Zepatier for the management of HCV in the Italian scenario Rolli, F. R.
2018
9 p. 1365-1374
artikel
38 Effect of financial inclusion on out-of-pocket health expenditure: empirics from Ghana Koomson, Isaac

9 p. 1411-1425
artikel
39 Effects of pay-for-performance for primary care physicians on diabetes outcomes in single-payer health systems: a systematic review Gupta, Neeru

9 p. 1303-1315
artikel
40 Efficiency ratio and rocketing drug prices: old concerns and new possibilities Capri, Stefano

9 p. 1273-1277
artikel
41 Efficient health research and improving Europeans’ health Antoñanzas, Fernando
2015
9 p. 913-915
artikel
42 Endogenous risk-taking and physical appearance of sex workers Egger, Peter H.
2014
9 p. 941-949
artikel
43 EQ-5D in skin conditions: an assessment of validity and responsiveness Yang, Yaling
2014
9 p. 927-939
artikel
44 EQ-5D-5L Portuguese population norms Ferreira, Pedro L.

9 p. 1411-1420
artikel
45 Equity in healthcare utilization in Canada’s publicly funded health system: 2000–2014 Hirello, Laura

9 p. 1519-1533
artikel
46 Examining unpriced risk heterogeneity in the Dutch health insurance market Withagen-Koster, A. A.
2018
9 p. 1351-1363
artikel
47 Exploring the determinants of endocrinologist visits by patients with diabetes Andrade, Luiz Flavio
2016
9 p. 1173-1184
artikel
48 Ex-post moral hazard in the health insurance market: empirical evidence from German data Thönnes, Stefanie

9 p. 1317-1333
artikel
49 Funding orphan medicinal products beyond price: sustaining an ecosystem de Sola-Morales, Oriol

9 p. 1283-1286
artikel
50 Gender-specific practice styles and ambulatory health care expenditures Kaiser, Boris
2016
9 p. 1157-1179
artikel
51 General population normative data for the EQ-5D-3L in the five largest European economies Janssen, Mathieu F.

9 p. 1467-1475
artikel
52 General practitioners’ income and activity: the impact of multi-professional group practice in France Cassou, Matthieu

9 p. 1295-1315
artikel
53 Health burden and costs of obesity and overweight in Germany: an update Lehnert, Thomas
2014
9 p. 957-967
artikel
54 Health care costs of borderline personality disorder and matched controls with major depressive disorder: a comparative study based on anonymized claims data Bode, Katharina
2016
9 p. 1125-1135
artikel
55 Health inequality indices and exogenous risk factors: an illustration on Luxembourgish workers Mussard, Stéphane
2018
9 p. 1285-1301
artikel
56 Health state utilities associated with attributes of treatments for hepatitis C Matza, Louis S.
2014
9 p. 1005-1018
artikel
57 Health state utility values (QALY weights) for Huntington’s disease: an analysis of data from the European Huntington’s Disease Network (EHDN) Hawton, Annie

9 p. 1335-1347
artikel
58 How French general practitioners respond to declining medical density: a study on prescription practices, with an insight into opioids use Silhol, Julien

9 p. 1391-1398
artikel
59 HTA methodology and value frameworks for evaluation and policy making for cell and gene therapies Coyle, Doug

9 p. 1421-1437
artikel
60 Human papillomavirus in Italy: retrospective cohort analysis and preliminary vaccination effect from real-world data Marcellusi, A.

9 p. 1371-1379
artikel
61 Identifying factors associated with high use of acute care in Canada: a population-based retrospective study Zhang, Mengmeng

9 p. 1505-1515
artikel
62 Impact of increasing treatment rates on cost-effectiveness of subcutaneous immunotherapy (SCIT) in respiratory allergy: a decision analytic modelling approach Richter, Ann-Kathrin
2018
9 p. 1229-1242
artikel
63 Improving risk equalization with constrained regression Kleef, Richard C. van
2016
9 p. 1137-1156
artikel
64 Incentivizing research into the effectiveness of medical devices Drummond, Michael
2016
9 p. 1055-1058
artikel
65 Long-term cost of breast cancer treatment to the United States Medicare Program by stage at diagnosis Grady, Ian

9 p. 1365-1370
artikel
66 Looking into the black box of “Medical Innovation”: rising health expenditures by illness type Breyer, Friedrich

9 p. 1601-1612
artikel
67 Mapping of the acromegaly quality of life questionnaire to ED-5D-5L index score among patients with acromegaly Wang, Kailu

9 p. 1381-1391
artikel
68 Mapping of the EORTC QLQ-C30 to EQ-5D-5L index in patients with lymphomas Xu, Richard Huan

9 p. 1363-1373
artikel
69 Methodological challenges in assessing the impact of comorbidities on costs in Alzheimer’s disease clinical trials Kahle-Wrobleski, Kristin
2014
9 p. 995-1004
artikel
70 Modelling the cost-effectiveness of person-centred care for patients with acute coronary syndrome Pirhonen, Laura

9 p. 1317-1327
artikel
71 Modest risk-sharing significantly reduces health plans’ incentives for service distortion Brammli-Greenberg, Shuli

9 p. 1359-1374
artikel
72 Modifying the quality-adjusted life year calculation to account for meaningful change in health-related quality of life: insights from a pragmatic clinical trial McClure, Nathan S.

9 p. 1441-1451
artikel
73 Multiplicative modelling of EQ-5D-3L TTO and VAS values Shafie, Asrul Akmal

9 p. 1411-1420
artikel
74 No gain in pain: psychological well-being, participation, and wages in the BHPS Lagomarsino, Elena

9 p. 1375-1389
artikel
75 Out-migration and attrition of physicians and dentists before and after EU accession (2003 and 2011): the case of Hungary Varga, Júlia
2016
9 p. 1079-1093
artikel
76 Parallel imports and a mandatory substitution reform: a kick or a muff for price competition in pharmaceuticals? Granlund, David
2014
9 p. 969-983
artikel
77 Patient hospital choice for hip replacement: empirical evidence from the Netherlands Beukers, Puck D. C.
2013
9 p. 927-936
artikel
78 People’s perception and cost-effectiveness of home confinement during an influenza pandemic: evidence from the French case Orset, Caroline
2018
9 p. 1335-1350
artikel
79 People’s perception and cost-effectiveness of home confinement during an influenza pandemic: evidence from the French case Orset, Caroline

9 p. 1335-1350
artikel
80 Pharmaceutical pricing dynamics in an internal reference pricing system: evidence from changing drugs’ reimbursements Costa, Eduardo

9 p. 1497-1518
artikel
81 Population norms in France with EQ-5D-5L: health states, value indexes, and VAS Gautier, Laurène

9 p. 1517-1530
artikel
82 Population preferences for non-pharmaceutical interventions to control the SARS-CoV-2 pandemic: trade-offs among public health, individual rights, and economics Mühlbacher, Axel C.

9 p. 1483-1496
artikel
83 Potential determinants of deductible uptake in health insurance: How to increase uptake in The Netherlands? Winssen, K. P. M. van
2015
9 p. 1059-1072
artikel
84 Preferences for home- and community-based long-term care services in Germany: a discrete choice experiment Lehnert, T.
2018
9 p. 1213-1223
artikel
85 Preferences for public involvement in health service decisions: a comparison between best-worst scaling and trio-wise stated preference elicitation techniques Erdem, Seda
2016
9 p. 1107-1123
artikel
86 Prescription opioids and economic hardship in France Natali, Ilaria

9 p. 1473-1504
artikel
87 Pricing vaccines and drugs in Europe: worth differentiating? Garattini, Livio

9 p. 1345-1348
artikel
88 Public preferences for policies promoting a healthy diet: a discrete choice experiment Dieteren, C. M.

9 p. 1429-1440
artikel
89 Reassessing the impact of health expenditure on income growth in the face of the global sanitary crisis: the case of developing countries Gaies, Brahim

9 p. 1415-1436
artikel
90 Self vs. other, child vs. adult. An experimental comparison of valuation perspectives for valuation of EQ-5D-Y-3L health states Lipman, S. A.

9 p. 1507-1518
artikel
91 Should administrative costs in health insurance be included in the risk-equalization? An analysis of five countries Douven, Rudy

9 p. 1437-1453
artikel
92 Some adjustments to the human capital and the friction cost methods Targoutzidis, Antonis
2018
9 p. 1225-1228
artikel
93 Some economics on personalized and predictive medicine Antoñanzas, F.
2014
9 p. 985-994
artikel
94 Stratified medicine in schizophrenia: how accurate would a test of drug response need to be to achieve cost-effective improvements in quality of life? Jin, Huajie

9 p. 1425-1435
artikel
95 Tackling the chronic disease burden: are there co-benefits from climate policy measures? Vandenberghe, Désirée
2018
9 p. 1259-1283
artikel
96 The attractiveness of jobs in the German care sector: results of a factorial survey Kroczek, Martin

9 p. 1547-1562
artikel
97 The cost-effectiveness of transcatheter aortic valve implantation: exploring the Italian National Health System perspective and different patient risk groups Lorenzoni, V.

9 p. 1349-1363
artikel
98 The costs and consequences of obesity in Germany: a new approach from a prevalence and life-cycle perspective Effertz, Tobias
2015
9 p. 1141-1158
artikel
99 The costs of celiac disease: a contingent valuation in Switzerland Soler, Laia

9 p. 1487-1505
artikel
100 The economic impact of multiple sclerosis to the patients and their families in Norway Svendsen, B.
2018
9 p. 1243-1257
artikel
101 The effect of economic growth on obesity for the most obese countries: new evidence from the obesity Kuznets curve Aydin, Mucahit

9 p. 1349-1358
artikel
102 The effect of informal caregiving on medication: evidence from administrative data Stroka-Wetsch, Magdalena

9 p. 1535-1545
artikel
103 The effect of mental and physical health problems on sickness absence Bryan, Mark L.

9 p. 1519-1533
artikel
104 The effects of health shocks on family status: do financial incentives encourage marriage? Ehlert, Andree

9 p. 1393-1409
artikel
105 The hidden economic burden of air pollution-related morbidity: evidence from the Aphekom project Chanel, Olivier
2015
9 p. 1101-1115
artikel
106 The impact of ageing on health care expenditures: a study of steepening Gregersen, Fredrik Alexander
2013
9 p. 979-989
artikel
107 The impact of cost-sharing on prescription drug demand: evidence from a double-difference regression kink design Gamba, Simona

9 p. 1591-1599
artikel
108 The impact of the diabetes management incentive on diabetes-related services: evidence from Ontario, Canada Thavam, Thaksha

9 p. 1279-1293
artikel
109 The impact of tobacco control policies on smoking initiation in eleven European countries Palali, Ali

9 p. 1287-1301
artikel
110 The social value of gambling: surplus estimates by gambling types for France Miéra, Maxence

9 p. 1531-1543
artikel
111 Timing matters: worker absenteeism in a weekly backward rotating shift model Frick, Bernd

9 p. 1399-1410
artikel
112 Validity and responsiveness of the EQ-5D and the KIDSCREEN-10 in children with ADHD Bouwmans, Clazien
2013
9 p. 967-977
artikel
113 Values for health states with different life durations Scalone, Luciana
2014
9 p. 917-925
artikel
114 Variation in the methodological approach to productivity cost valuation: the case of prostate cancer Hanly, Paul

9 p. 1399-1408
artikel
115 Variations in external reference pricing implementation: does it matter for public policy? Gill, Jennifer

9 p. 1375-1397
artikel
116 What matters in type 2 diabetes mellitus oral treatment? A discrete choice experiment to evaluate patient preferences Mühlbacher, Axel
2015
9 p. 1125-1140
artikel
117 What should we know about the person behind a TTO? Nooten, Floortje van
2018
9 p. 1207-1211
artikel
118 Work productivity loss and indirect costs associated with new cardiovascular events in high-risk patients with hyperlipidemia: estimates from population-based register data in Sweden Banefelt, J.
2015
9 p. 1117-1124
artikel
                             118 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland